The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 179: 1595-1604.
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haniffa, M. A.
Right arrow Articles by Collin, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haniffa, M. A.
Right arrow Articles by Collin, M. P.

Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells1

Muzlifah A. Haniffa*,{dagger},{ddagger}, Xiao-Nong Wang*, Udo Holtick*, Michelle Rae*, John D. Isaacs{dagger}, Anne M. Dickinson*, Catharien M. U. Hilkens2,{dagger} and Matthew P. Collin2,3,*

* Hematological Sciences, {dagger} Musculoskeletal Research Group, and {ddagger} Dermatological Sciences, Institute of Cellular Medicine, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, United Kingdom

Bone marrow mesenchymal stem cells (MSC) have potent immunosuppressive properties and have been advocated for therapeutic use in humans. The nature of their suppressive capacity is poorly understood but is said to be a primitive stem cell function. Demonstration that adult stromal cells such as fibroblasts (Fb) can modulate T cells would have important implications for immunoregulation and cellular therapy. In this report, we show that dermal Fb inhibit allogeneic T cell activation by autologously derived cutaneous APCs and other stimulators. Fb mediate suppression through soluble factors, but this is critically dependent on IFN-{gamma} from activated T cells. IFN-{gamma} induces IDO in Fb, and accelerated tryptophan metabolism is at least partly responsible for suppression of T cell proliferation. T cell suppression is reversible, and transient exposure to Fb during activation reprograms T cells, increasing IL-4 and IL-10 secretion upon restimulation. Increased Th2 polarization by stromal cells is associated with amelioration of pathological changes in a human model of graft-vs-host disease. Dermal Fb are highly clonogenic in vitro, suggesting that Fb-mediated immunosuppression is not due to outgrowth of rare MSC, although dermal Fb remain difficult to distinguish from MSC by phenotype or transdifferentiation capacity. These results suggest that immunosuppression is a general property of stromal cells and that dermal Fb may provide an alternative and accessible source of cellular therapy.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Action Medical Research United Kingdom (RTF1155), Leukaemia Research Fund United Kingdom (06016), and European Commission (MRTN-CT-2004-512253 "TRANSNET").

2 C.M.U.H. and M.P.C. jointly supervised this research.

3 Address correspondence and reprint requests to Dr. Matthew P. Collin, Hematological Sciences, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, U.K. E-mail address: matthew.collin{at}ncl.ac.uk

4 Abbreviations used in this paper: BM, bone marrow; MSC, mesenchymal stem cell; DC, dendritic cell; moDC, monocyte-derived DC; GVHD, graft-vs-host disease; Fb, fibroblast; CFU-F, fibroblast CFU; LC, Langerhans cell; 1-MT, 1-methyl-L- tryptophan.




This article has been cited by other articles:


Home page
BloodHome page
H. Karlsson, S. Samarasinghe, L. M. Ball, B. Sundberg, A. C. Lankester, F. Dazzi, M. Uzunel, K. Rao, P. Veys, K. Le Blanc, et al.
Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses
Blood, August 1, 2008; 112(3): 532 - 541.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.